Adverse events after immunisation with aluminium-containing DTP vaccines: systematic review of the evidence
- 1 February 2004
- journal article
- research article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 4 (2) , 84-90
- https://doi.org/10.1016/s1473-3099(04)00927-2
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Hepatitis B vaccination and multiple sclerosis: evidence from a systematic reviewJournal of Viral Hepatitis, 2003
- Systematic review of the effects of pertussis vaccines in childrenVaccine, 2003
- The Brighton Collaboration: addressing the need for standardized case definitions of adverse events following immunization (AEFI)Vaccine, 2002
- Macrophagic Myofasciitis: a summary of Dr. Gherardi’s presentationsVaccine, 2002
- Aluminum salts in vaccines—US perspectiveVaccine, 2002
- Macrophagic myofasciitis: an emerging entityThe Lancet, 1998
- Booster vaccination against diphtheria and tetanus in man. Comparison of calcium phosphate and aluminium hydroxide as adjuvants—IIVaccine, 1995
- SYMPTOMS AFTER PRIMARY IMMUNISATION WITH DTP AND WITH DT VACCINEThe Lancet, 1984
- REACTIONS AND ANTIBODY RESPONSES TO REINFORCING DOSES OF ADSORBED AND PLAIN TETANUS VACCINESThe Lancet, 1979
- Advantages of Aluminium Hydroxide Adsorbed Combined Diphtheria, Tetanus, and Pertussis Vaccines for the Immunization of InfantsBMJ, 1969